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Abstract To demonstrate that portable electrospin-
ning devices can spin a wide range of polymers into
submicron fibres and provide a mesh quality compa-
rable to those produced with benchtop machines. We
have designed a small, battery-operated electrospin-
ning apparatus which enables control over the voltage
and the flow rate of the polymer solution via a
microcontroller. It can be used to electrospin a range
of commonly used polymers including poly(e-capro-
lactone), poly(p-dioxanone), poly(lactic-co-glycolic
acid), poly(3-hydroxybutyrate), poly(ethylene oxide),
poly(vinyl acohol) and poly(vinyl butyral). Moreover,
electrospun meshes are produced with a quality
comparable to a benchtop machine. We also show
that the portable apparatus is able to electrospray
beads and microparticles. Finally, we highlight the
potential of the device for wound healing applications
by demonstrating the possibility of electrospinning
onto pig and human skins. Portable electrospinning
devices are still at an early stage of development but
they could soon become an attractive alternative to
benchtop machines, in particular for uses that require
mobility and a higher degree of flexibility, such as for
wound healing applications.
Keywords Electrospinning  Electrospraying 
Nanofibres  Portable device  Tissue engineering
scaffolds  Wound dressings  Wound healing
Introduction
Electrospinning is currently one of the most successful
methods used to produce polymer submicron fibres.
Compared to other techniques, it has the advantages of
being simple, versatile, and cost effective. Similarly to
electrospraying, which produces particles, electros-
pinning uses high voltage electrical charges to draw
nanoscale and microscale fibres from a polymer
solution (Reneker and Yarin 2008).
The submicron scale dimensions of the fibres and the
high surface area to volume ratio of the meshes provide
electrospun materials with unique properties. So far,
they have found applications in many areas including
aerospace and aviation, automotive, electronics and
semiconductors, energy, filtration, textiles, cosmetics,
and medicine. In the medical area, electrospun fibres can
be used as scaffolds for tissue engineering, wound
healing devices and drug-delivery systems. Their
P.-A. Mouthuy
Nuffield Department of Orthopaedics, Rheumatology and
Musculoskeletal Sciences, Botnar Institute of
Musculoskeletal Sciences, University of Oxford,
Oxford OX3 7LD, UK
e-mail: pierre-alexis.mouthuy@ndorms.ox.ac.uk
P.-A. Mouthuy  L. Groszkowski  H. Ye (&)
Department of Engineering Science, Institute of
Biomedical Engineering, University of Oxford, Old Road





Biotechnol Lett (2015) 37:1107–1116
DOI 10.1007/s10529-014-1760-6
potential as scaffolds for tissue engineering applications
mainly relies on their ability to mimic the extracellular
matrix surrounding cells in tissues and organs. In
particular, they have been shown to improve cell
adhesion, proliferation and differentiation (Rho et al.
2006; Zonari et al. 2012; Downing et al. 2013).
Promising results have been reported for their use in
the repair of various biological tissues including skin,
tendon, ligament, bone and cartilage (Kumbar et al.
2008; Sahoo et al. 2006; Aviss et al. 2010; Mouthuy
et al. 2010; Alves da Silva et al. 2010). As a wound
dressing, the high porosity, small pore size and high
specific surface area of the meshes provide a physical
barrier against germs and are favourable to exude fluid
from the wound. Meshes can be used to prevent
postsurgery adhesions (Zong et al. 2004). Therapeutic
and antimicrobial agents can be incorporated into the
fibres to improve the quality of the healing and minimise
the risk of infection (Zamani et al. 2013; Yang et al.
2012; Zong et al. 2004). Another approach proposed to
assist the healing process is to electrospun living cells
together with the fibres (Townsend-Nicholson and
Jayasinghe 2006; Jayasinghe 2013).
A typical electrospinning setup consists of a high
voltage power supply unit, a syringe pump unit and a
set of electrodes. Although not necessary for the
process itself, syringe pumps are crucial to provide
high quality and reproducible samples. Over the last
decade, the development of electrospinning equip-
ment for research use has been driven by the need for
better control over the parameters involved to lead to
better reproducibility. For industrial applications, the
main focus has been on scaling up the technology to
increase the rate of production. Here, we believe that
remodelling the cumbersome apparatus into a small
device could have advantages in terms of transport-
ability, flexibility of use and cost. For medical
applications, the ability to spray or spin directly onto
a wound with a small device could allow new ways to
improve tissue healing and reduce scar formation.
Several attempts have been made to miniaturise the
electrospinning technology into small portable
devices. However, patents have been a major brake
to the dissemination of these devices as they have
remained unexploited. A series of portable electrodi-
spersing devices which could be handheld, battery-
powered and offering controlled fluid delivery with
piezoelectric diaphragm pumps were developed in
Oxford by Pirrie and Coffee (Coffee 1998; Pirrie and
Coffee 2003). Although these were aimed at elec-
trospraying applications, the authors briefly demon-
strated the potential for producing fibres. Devices
dedicated to electrospinning were later developed by
Reneker’s group at the University of Akron, which
proposed a battery-powered device with a reservoir to
provide the fluid (Smith et al. 2004). Shortly after, in
2006, Greiner and collaborators from the University of
Marburg disclosed a handheld electrospinning equip-
ment with which they performed demonstrations
(Greiner and Wendorff 2007). The high voltage was
supplied by standard batteries and the device had a
modular construction to enable the spinning of differ-
ent polymer solutions which were provided from vials.
A device based on a similar principle has later been
proposed by Ramakrishna’s group at the University of
Singapore (Liu et al. 2010). More recently, a simple
device involving a finger-pressed syringe was devel-
oped at the University of Qingdao (Long et al. 2012).
However, for all these devices developed, very little
technical details were released and there has been no
follow up on the potential applications or actual uses.
Moreover, apart from the electrospraying devices,
none of the apparatus mentioned above offers a
controlled fluid delivery by electronic components.
Here, we propose a novel portable electrospinning
apparatus. Both the voltage and flow rate can be
adjusted via a microcontroller over a range of values
suitable for most electrospinning and electrospraying
applications. We show its ability to produce submi-
cron fibres and particles made of several polymers
commonly used in the field. We also compare the
performance of the device to a typical benchtop setup.
Finally, we demonstrate the possibility of electrospin-
ning directly onto skin to highlight the potential of the
apparatus for wound healing applications.
Materials and methods
Electrospinner: components and manufacture
To provide the high voltage, a converter model F101
(EMCO High Voltage Corporation, US) was selected.
A T-NA linear actuator model TNA08A25-S (Zaber
Technologies Inc., Canada) used in combination with
the MAX-232 (RS, Electrocomponents plc, UK) was
used to form a syringe pump. The actuator has a speed
resolution of 0.22 lm/s (flow rate accuracy using
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cartridges modified from 3 ml BD syringes: 48 ll/h)
and thrust force of 50 N. A PIC16 microcontroller
(Microchip Technology Inc., US) and a LCD 8 9 2
character display (RS, Electrocomponents plc, UK)
were used to provide user interface for the operator to
control the device. A pack of 10 rechargeable NiMH AA
batteries (RS, Electrocomponents plc, UK) was assem-
bled to supply sufficient power to the device to function
for approx. 2 h. Generic electronic components were
used to complete the circuit board and to allow user
input generic switches and push buttons were used.
Software, electrical components and the SLS (selective
laser sintering) printed casing were assembled at Triteq
Ltd (UK). The pen extension used for manual spinning
was made of a 40 cm long Teflon tube (Sigma-Aldrich)
ending with a pen-shaped casing. The tube was secured
in the pen with appropriate fittings.
Preparation of polymer solutions
Poly(e-caprolactone) (PCL, Mw 80 kDa, Sigma-
Aldrich) was dissolved into 1,1,1,3,3,3- hexafluoroiso-
propanol (HFIP, Apollo Scientific Ltd., Cheshire, UK)
at 8 % (w/v). Poly(p-dioxanone) (PDO, viscosity 1.5-
2.2 dl/g, Sigma-Aldrich) was dissolved into HFIP at
9 % (w/v). Poly(lactic-co-glycolic acid) (PLGA 75:25,
Mw 66-107 kD, Sigma-Aldrich) was added in HFIP at
17 % (w/v) and 2.5 % (w/v). Poly(3-hydroxybutyrate)
(PHB, Mw 6kD, Polysciences Europe GmbH, Eppel-
heim, Germany) was dissolved at 4.5 % (w/v) in HFIP.
Poly(vinyl acohol) (PVA, Mw 89-98 kD, 99 % hydro-
lysed, Sigma-Aldrich) was dissolved at 10 % (w/v) in
deionised water at 90 C for at least 6 h under constant
stirring. Poly(ethylene oxide) (PEO, Mw 400 kD,
Sigma-Aldrich) was added to deionised water at 4 %
(w/v). Poly(vinyl butyral) (PVB, Mowital B75H, Kura-
ray Europe GmbH, Hattersheim, Germany) was dis-
solved at 8 % (w/v) in ethanol/methanol (9:1 v/v).
Alginate (sodium alginate, 100–300 cP, Sigma-Aldrich)
was dissolved in deionised water at 2 % (w/v) at 90 C
for 3 h with gentle stirring. All solutions were agitated at
room temperature on a roller for at least 24 h prior
electrospinning or electrospraying.
Electrospinning
Polymer solutions were loaded into 2 ml cartridges.
Cartridges were produced by shortening both the main
body and the plunger of 3 ml syringes with a Luer lock
(BD, Oxford, UK). The syringes were fitted with
blunted needles, gauge 21. Electrospinning with the
portable electrospinner was performed horizontally
with a distance of 20 cm and a flow rate of 1 ml/h. The
voltage was adjusted with each polymer solution to
obtain a stable jet. Fibres were collected onto a
stainless steel plate covered with aluminium foil. The
plate was grounded to the apparatus via a cable.
Experiments involving the use of HFIP solvent were
carried out within a glove box purged with nitrogen.
Electrospinning on skin was performed with the pen
extension, manually maintained at constant distance
by the experimenter during the spinning. The ground
cable was kept in contact with the skin. Demonstra-
tions performed with pig skin samples were carried out
with the PDO solution. Demonstrations performed on
human volunteers were carried out with the PEO
solution. Benchtop electrospinning was performed
using an apparatus described by Mouthuy et al. (2010).
Electrospraying
The alginate solution was electrosprayed at 2 ml/h
into a grounded 0.102 M CaCl2 bath 6 cm underneath
the tip of the extension. The 2.5 % PLGA solution was
electrosprayed at 20 cm onto a flat stainless steel
collector covered with aluminium foil with a flow rate
of 0.6 ml/h.
Scanning electron microscopy (SEM)
Samples were mounted on an aluminium stub using a
carbon adhesive disk and gold coated using a SC7620
Mini Sputter Coater System (Quorum Technologies
Ltd, East Sussex). High resolution images were taken
using an environmental SEM (Carl Zeiss Evo LS15
Variable Pressure SEM). Fibre diameters were mea-
sured using ImageJ software (by W. S. Rasband, US




The portable electrospinner is displayed in Fig. 1. The
high voltage converter, the linear actuator and the
batteries are efficiently packed in the casing to
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minimise the size of the apparatus (Fig. 1a). As shown
in Fig. 1b, cartridges are located in a separate
compartment to allow safe and easy replacement.
The modified syringes used as cartridges are seen in
Fig. 1c. The total weight of the apparatus is 1.11 kg.
The electrospinning can be used by spinning directly
from the cartridge (Fig. 1d) or with the pen extension
(Fig. 1e). The voltages can be selected between 0 and
14 kV and a wide choice of flow rates were pre-set
between 0 and 10 ml/h. Values are indicated on the
LCD screen during use. Batteries were able to provide
enough power for the device to run for about 105 min
at 13 kV and 1 ml/h.
Electrospinning performances
As seen in Fig. 2, the electrospinner is able to spin
fibres made of various polymers including PCL, PDO,
PLGA, PHB, PEO, PVA and PVB. Most of these
materials are commonly used in electrospinning
research and the range includes both water-soluble
and non-water-soluble polymers. Electrospinning
parameters and fibres diameters are indicated in
Table 1. The average diameters varied between
268 nm and 1,607 nm depending on the solutions
and parameters used. This demonstrates the ability of
the device to produce both sub- and sup-micron fibres.
Fig. 1 Design of the portable electrospinning apparatus.
a Exploded view of the CAD drawing assembly of the device
(1. high voltage converter, 2. linear actuator, 3. battery pack).
b Separated compartment for cartridges, accessible from
removable lid. c Cartridges used in this study. d Fibres being
electrospun directly from the device. e Fibres being electrospun
manually via a pen extension connected to the device
1110 Biotechnol Lett (2015) 37:1107–1116
123
In Fig. 3, we compare the morphologies of PCL
electrospun fibres produced with the portable device
(with and without extension) to those produced with a
benchtop device. SEM images (Fig. 3a–c) show that
similar structures were obtained. Moreover, as shown
in Fig. 3d, the fibre diameter distribution profiles are
almost identical, regardless the electrospinning appa-
ratus used. In all three configurations (benchtop,
portable and portable with extension), PCL scaffolds
display two peaks of diameters around 350 nm and
1,300 nm. This is reflected in the high magnification
SEM images where both sub- and sup-micron fibres
are observed. Parameters and fibres diameters are
indicated in Table 2. Although the portable device
currently offers lower resolutions for both the voltage
and the flow rate, no significant change of the average
fibre diameter is observed. These results demonstrate
the equivalence between a portable apparatus and a
traditional benchtop setup since both produce similar
scaffolds using identical process parameters.
Electrospraying performances
The ability of the portable apparatus to electrospray
beads and particles is shown in Fig. 4. Electrospraying
parameters and measured particle diameters are listed
in Table 3. These results confirm the suitability of the
portable apparatus to be used as an electrospraying
device. In particular, this suggests the potential of
using the device for cell electrospraying applications
(Jayasinghe et al. 2006).
In situ electrospinning
Results of in situ electrospinning experiments are
presented in Figs. 5 and 6. Electrospinning parameters
are displayed in Table 4. Fibres were successfully
spun on both pig and human skins. The duration of
electrospinning was selected to make the area of
collection easily observable although a few minutes of
electrospinning are sufficient to deposit several layers
Fig. 2 Fibres electrospun with the portable device from
different polymer solutions: a PCL 8 % in HFIP, b PCL 8 %
in HFIP, c PDO 9 % in HFIP, d PLGA 17 % in HFIP, e PHB
8 % in HFIP, f PEO 4 % in H2O, g PVA 10 % in H2O, h PVB
4.5 % in Ethanol/methanol. Scale bars represent 10 lm
Table 1 Electrospinning parameters used for each polymer solution and average fibre diameters observed in the resulting scaffolds
Polymer Solvent Concentration (%w/v) Voltage (kV) F (ml/h) Distance (cm) Fibre diameter (nm)
PCL HFIP 8 8.1 1 20 786 ± 592
PCL HFIP 8 11 1 20 566 ± 258
PDO HFIP 9 10 1 20 982 ± 194
PLGA HFIP 17 9.6 1 20 1,405 ± 626
PHB HFIP 4.5 10.6 1 20 853 ± 273
PEO H2O 4 10 1 20 268 ± 74
PVA H2O 10 13.5 1 20 310 ± 96
PVB Ethanol/methanol (9:1, v/v) 8 13.1 1 20 1,607 ± 207
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of electrospun fibres. Faster deposition rates could be
achieved using a multi-nozzle setup or with a modified
extension allowing multi-jet electrospinning. Fig-
ure 5a shows electrospun fibres being spun directly
on a skin defect with the portable tool and the pen
extension. The area of deposition of the fibres was
reduced by the use of a mask, as shown in Fig. 5b. The
electrospun mesh becomes completely transparent
after being moisturised (Fig. 5c), allowing clear
visualisation of the skin defect through the fibres.
After drying, the mesh recovers its opacity. This
interesting property may be used to monitorthe healing
of a wound without removing a deposited electrospun
patch.
Future directions of portable electrospinning tools
The emergence of portable electrospinning technolo-
gies benefits from the progressive miniaturisation of
batteries, high voltage converters and linear actuators.
Fig. 3 Morphologies of PCL scaffolds produced with benchtop
and portable electrospinning devices. a Mesh electrospun with
benchtop electrospinning apparatus. b Mesh electrospun with
the portable apparatus. c Mesh electrospun with the portable
apparatus and the pen extension. d Frequency of the fibre
diameters observed with each electrospinning setup. Experi-
ments were performed with PCL 8 % in HFIP and identical
electrospinning parameters with each setup
Table 2 Electrospinning parameters used for the comparison of performances between a benchtop apparatus and the portable device
Apparatus Polymer solution (w/v) Voltage (kV) F (ml/h) Distance (cm) Fibre diameter (nm)
Benchtop PCL 8 % in HFIP 8.1 ± 0.1 1 ± 0.003 20 889 ± 577
Portable PCL 8 % in HFIP 8.1 ± 0.2 1 ± 0.048 20 786 ± 592
Portable, with extension PCL 8 % in HFIP 8.1 ± 0.2 1 ± 0.048 20 747 ± 535
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Eventually, it may lead to the design of pen-size
electrodispersers. In the short term, these technologies
are likely to be of benefit to academics as well as to
industrial users. Table 5 lists the advantages and
inconveniences of a portable tool compared to a
benchtop device. The character of portability makes it
possible to use the equipment in various places
including laboratory benches, fume hoods (for organic
solvent), cell culture hoods (for cell electrospinning/
spraying), clean rooms (for implant preparation),
classrooms (for demonstration purposes), and even
outdoors. Since it allows more flexibility in their use
such as in terms of direction of spinning and target,
portable devices may lead to the discovery of new
electrospinning applications. In particular, it may
become simpler to explore the combination of elec-
trospinning with other existing technologies such as
with 3D printing. Another major advantage of the
portable device is their affordability, since all elec-
tronic components involved are relatively inexpen-
sive. In the long term, portable electrospinning
technologies are likely to help for wound healing
management and other conditions that may require
controlled release of bioactive components. They
could be particularly useful to regenerative medicine
approaches using electrospinning and electrospraying
of living cells. However, there is still work to be done
to demonstrate the real benefit of in situ electrospin-
ning and to ensure that the apparatus complies with
safety regulations.
Conclusions
A unique electrospinning apparatus, which is portable
and battery-powered, is presented. Both the voltage
and flow rate can be adjusted over a range of values
suitable for most electrospinning applications via a
microcontroller. A pen extension device can be used
for manual spinning. The apparatus was able to
electrospin sub- and sup-micron fibres made of several
polymers commonly used in the field of electrospin-
ning and the quality of the non-woven meshes was
similar to those made with a benchtop device.
Electrospraying beads and microparticles was also
achieved. Finally, we shown the possibility of elec-
trospinning directly onto skin. Overall, these results
demonstrate that portable electrospinning devices
could become an attractive alternative to existing
benchtop machines in the near future. They offer
Fig. 4 Morphologies of alginate beads and PLGA microparticles produced with the portable devices. a Beads produced from a 2 %
alginate solution electrosprayed into a grounded CaCl2 bath. b Particles sprayed from a solution of 2.5 % PLGA in HFIP
Table 3 Electrospraying parameters used for the alginate and PLGA solutions
Polymer Solvent Concentration (%w/v) Voltage (kV) F (ml/h) Distance (cm) Particle diameter (lm)
Alginate H2O 2 7.1 2 6 369 ± 105
PLGA HFIP 2.5 11.2 0.6 20 1.9 ± 0.7
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Fig. 5 In situ electrospinning on pig skin. a PDO electrospun
fibres being spun directly on a skin defect with the portable tool
and the pen extension. b Skin defect fully covered by an
electrospun patch (dashed circle electrospun fibres deposition
area). c The skin defect can clearly be seen by moisturising the
mesh. After drying, the patch recovers its opacity
Fig. 6 Examples of PEO
patches created on the a arm
and b hand of healthy
volunteers
Table 4 Solutions and parameters used for the electrospinning experiments carried out on skin
Targeted skin Polymer solution (w/v) Voltage (kV) F (ml/h) Distance (cm) Duration (min)
Pig PDO 9 % in HFIP 10 1 20 30
Human PEO 4 % in H2O 10 1 20 5–15
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advantages in terms of cost, transportability and
flexibility of use which may be particularly beneficial
to the development of new wound healing strategies.
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